Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
71 hedge funds and large institutions have $150M invested in Calithera Biosciences, Inc in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 11 closing their positions.
373% more call options, than puts
Call options by funds: $1.75M | Put options by funds: $369K
72% more capital invested
Capital invested by funds: $87.1M → $150M (+$62.9M)
71% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 17
8% less funds holding
Funds holding: 77 → 71 (-6)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.21M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$1.15M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$916K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$714K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$693K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$1.44M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$335K |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$309K |
| 4 |
Millennium Management
New York
|
-$254K |
| 5 |
Morgan Stanley
New York
|
-$215K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
76
Virtu Financial
New York
| – | -$49K | -610 | Closed |
|
|
TRCT
77
Tower Research Capital (TRC)
New York
| – | -$4K | -54 | Closed |
|
78
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$2K | -20 | Closed |
|
|
AWMS
79
Advocacy Wealth Management Services
Atlanta,
Georgia
| – | -$1K | -10 | Closed |
|
80
Fidelity Investments
Boston,
Massachusetts
| – | -$1K | -10 | Closed |
|
|
IA
81
IFP Advisors
Tampa,
Florida
| – | -$1K | -10 | Closed |
|
CALA Hedge Fund Activity: Q1 2019 in Review
71 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q1 2019, worth a combined $150M — up 72% from $87.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CALA and 5 opened new positions — a net loss of 6 holders — while 17 trimmed existing stakes and 29 added.
The largest buyer was Renaissance Technologies, adding an estimated $1.21M. The largest seller was BVF Inc, cutting an estimated $1.44M.
- 71 institutional investors held Calithera Biosciences, Inc (CALA) as of Q1 2019, down from 77 in Q4 2018.
- Funds reported $150M of Calithera Biosciences, Inc stock for Q1 2019, up 72% quarter-over-quarter.
- 5 funds opened new Calithera Biosciences, Inc positions in Q1 2019 and 11 closed out, a net change of -6 holders.
- The largest Calithera Biosciences, Inc buyer in Q1 2019 was Renaissance Technologies, an estimated $1.21M added.
- The largest Calithera Biosciences, Inc seller in Q1 2019 was BVF Inc, an estimated $1.44M sold.
Based on aggregated 13F filings for Q1 2019.